A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

Title
A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer
Authors
Keywords
-
Journal
GYNECOLOGIC ONCOLOGY
Volume 119, Issue 1, Pages 32-37
Publisher
Elsevier BV
Online
2010-07-03
DOI
10.1016/j.ygyno.2010.05.033

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now